• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Assessment of coronary thrombolysis.

作者信息

Geltman E M, Abendschein D R, Devries S R

出版信息

Cardiol Clin. 1987 Feb;5(1):55-66.

PMID:3548975
Abstract

The efficacy of coronary thrombolysis may be assessed by several invasive and noninvasive means, including coronary angiography, contrast and radionuclide angiography, thallium 201 or 99mTc-pyrophosphate scintigraphy, positron emission tomography, cardiac ultrasonography, electrocardiography, and analysis of plasma creatine kinase activity. Each technique has its own strengths and limitations, but when used in concert these methods may provide insight into the physiology of coronary reperfusion and the efficacy of reperfusion in individual patients and populations.

摘要

相似文献

1
Assessment of coronary thrombolysis.
Cardiol Clin. 1987 Feb;5(1):55-66.
2
[The study of the activity of creatine kinase in diagnosis of coronary reperfusion in patients with acute myocardial infarction after thrombolysis].[肌酸激酶活性测定在急性心肌梗死溶栓治疗后冠状动脉再灌注诊断中的研究]
Pol Merkur Lekarski. 1999 Aug;7(38):58-60.
3
[Non-invasive assessment of coronary reperfusion].[冠状动脉再灌注的无创评估]
Cardiologia. 1994 Dec;39(12 Suppl 1):311-6.
4
Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).中度至高度风险急性冠状动脉综合征患者中,心肌梗死溶栓治疗与心肌灌注分级、生物标志物及临床结局之间的关联:来自评估抗血小板和抗血栓药物预防PCI后微血管功能障碍及PCI后缺血的相对保护作用的随机试验——心肌梗死溶栓治疗30(PROTECT-TIMI 30)的观察结果
Am Heart J. 2006 Oct;152(4):756-61. doi: 10.1016/j.ahj.2006.04.016.
5
Value and limitations of thrombolytic therapy in early acute transmural myocardial infarction.溶栓治疗在早期急性透壁性心肌梗死中的价值与局限性
Cardiology. 1985;72(5-6):255-79. doi: 10.1159/000173884.
6
A score predicts failure of reperfusion after fibrinolytic therapy for acute myocardial infarction.一个评分可预测急性心肌梗死溶栓治疗后再灌注失败。
Am Heart J. 2003 Mar;145(3):508-14. doi: 10.1067/mhj.2003.184.
7
[Thrombolysis in acute transmural heart infarction: length of ischemia as a determinant of late results after 15 months].[急性透壁性心肌梗死的溶栓治疗:缺血时间作为15个月后远期结果的决定因素]
Z Kardiol. 1984 Apr;73(4):231-6.
8
Primary intracoronary stenting in comparison with intravenous rt-PA thrombolysis plus rescue intracoronary intervention in patients with acute myocardial infarction.急性心肌梗死患者冠状动脉内直接支架置入术与静脉注射rt-PA溶栓加挽救性冠状动脉介入治疗的比较
Chin Med J (Engl). 2002 Feb;115(2):163-5.
9
[Planar myocardial scintigraphy with 99mTc sestamibi for the evaluation of the infarct area and the efficacy of the thrombolytic therapy].
Minerva Cardioangiol. 1999 Mar;47(3):59-64.
10
Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings.急性心肌梗死中阿替普酶(50毫克)联合替罗非班溶栓与单独使用阿替普酶(100毫克)溶栓的安全性和有效性:初步研究结果。
Ital Heart J. 2001 Aug;2(8):605-11.

引用本文的文献

1
Tomographic and planar quantitation of perfusion defects on technetium 99m-labeled sestamibi scans: evaluation in patients treated with thrombolytic therapy for acute myocardial infarction.锝99m标记的甲氧基异丁基异腈扫描中灌注缺损的断层摄影和平面定量分析:对接受急性心肌梗死溶栓治疗患者的评估
J Nucl Cardiol. 1995 Mar-Apr;2(2 Pt 1):133-43. doi: 10.1016/s1071-3581(95)80024-7.
2
Experimental validation of a new quantitative method for the analysis of infarct size by cardiac perfusion tomography (SPECT).
Int J Card Imaging. 1993 Sep;9(3):201-12. doi: 10.1007/BF01145322.